Stock 600812 NORTH CHINA PHARMACEUTICAL COMPANY.LTD
Add to a list
To use this feature you must be a member
Log inSign up

All News North China Pharmaceutical Company.Ltd

Equities

600812

CNE000000D16

End-of-day quote Shanghai S.E.
Other stock markets
 06:00:00 2024-07-11 pm EDT 		5-day change 1st Jan Change
4.5 CNY -1.10% Intraday chart for North China Pharmaceutical Company.Ltd +5.63% -21.05%
Jun. 03 China Grants Marketing Approval for Ampicillin Sodium as Active Pharmaceutical Ingredient MT
May. 24 North China Pharmaceutical's Unit Passes GMP Inspection MT

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
China Grants Marketing Approval for Ampicillin Sodium as Active Pharmaceutical Ingredient
MT
North China Pharmaceutical's Unit Passes GMP Inspection
MT
North China Pharmaceutical Unit Gets China Nod for Rabies Vaccine
MT
North China Pharmaceutical Company.Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
North China Pharmaceutical Company.Ltd agreed to acquire the remaining 35.85% stake in NCPC Hebei Huamin Pharmaceutical Co., Ltd. from CCB Financial Asset Investment Co., Ltd. for CNY 670 million
CI
North China Pharmaceutical Company.Ltd Reports Earnings Results for the Full Year Ended December 31, 2023
CI
North China Pharmaceutical Subsidiary Gets Europe's Compliance Certification for Drug Raw Material
MT
Jizhong Energy Group Finance Co., Ltd announced that it has received CNY 1.3 billion in funding from Jizhong Energy Group Co.,Ltd., Jizhong Energy Resources Co., Ltd., North China Pharmaceutical Company.Ltd
CI
North China Pharmaceutical Gets Nod to Market Ampicillin API
MT
North China Pharmaceutical Company.Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023
CI
North China Pharmaceutical Company.Ltd(XSSC:600812) added to S&P Global BMI Index
CI
North China Pharmaceutical Company.Ltd(XSSC:600812) added to FTSE All-World Index
CI
North China Pharmaceutical Company.Ltd Reports Earnings Results for the Half Year Ended June 30, 2023
CI
Jizhong Energy Group Finance Co., Ltd announced that it expects to receive CNY 1.3 billion in funding from Jizhong Energy Group Co.,Ltd., Jizhong Energy Resources Co., Ltd., North China Pharmaceutical Company.Ltd
CI
North China Pharmaceutical Company Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
North China Pharma Unit Passes Compliance Inspection
MT
North China Pharmaceutical's Heart Drug Passes Regulatory Evaluation
MT
North China Pharmaceutical Company Ltd.(SHSE:600812) dropped from Shanghai Stock Exchange Health Care Sector Index
CI
North China Pharmaceutical Company Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
CI
North China Pharmaceutical Company Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 600812 Stock
  4. News North China Pharmaceutical Company.Ltd